Skip to main content
. 2020 Dec 22;12:13137–13148. doi: 10.2147/CMAR.S274447

Figure 1.

Figure 1

The expression of BLACAT1 in CRC tissues and cells, and its clinical parameters. (A) The expression level of BLACAT1 in CRC tissues and the corresponding normal tissues was detected by qRT-PCR. (B) A correlation analysis between the expression BLACAT1 and TNM stage was shown. (C) The relative expression of BLACAT1 in non-metastatic and metastatic human CRC tissues was determined by qRT-PCR. (D) The five-year survival rate of the patients with high and low expression of BLACAT1 was plotted by the Kaplan-Meier method. (E) The relative mRNA expression level of BLACAT1 was detected in cell lines (HIEC-6, HCT116, HT29, LOVO, and SW620). *P<0.05.

Abbreviations: BLACAT1, bladder cancer-associated transcript 1; CRC, colorectal cancer; TNM, tumor-node-metastasis.